IOVA
Iovance
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
IOVA Profile
Iovance Biotherapeutics, Inc.
A late-stage biotech company that develops novel T cell-based cancer immunotherapies
825 Industrial Road, Suite 400, San Carlos, California 94070
--
Iovance Biotherapeutics, Inc., is an emerging biotechnology company focused on the development and commercialization of cell therapy methods for cultured cells, using autologous tumor infiltrating lymphocytes (TILs) for the treatment of solid tumors such as metastatic melanoma. The company was founded in Nevada on September 17, 2007.